Conference Coverage

Renal denervation for hypertension rebounds


 

REPORTING FROM EUROPCR 2018

In the real RDN group, 24-hour ambulatory blood pressure fell from baseline to 6 months of follow-up to a statistically significant and clinically meaningful degree: by 9.0 mm Hg systolic, compared with 1.6 mm Hg in controls, and by 6.0 mm Hg diastolic versus 1.9 mm Hg with the sham procedure. Similarly, office blood pressure fell by 9.4/5.2 mm Hg with RDN, compared with 2.6/1.7 mm Hg in controls.

Dr. David Kandzari, director of interventional cardiology and chief scientific officer at the Piedmont Heart Institute in Atlanta Bruce Jancin/MDedge News

Dr. David E. Kandzari

Notably, 24-hour ambulatory systolic blood pressure was significantly lower in the RDN group around the clock.

“This may have important considerations with regard to pharmacotherapies with pharmacokinetic peaks and troughs in the early morning hours and late evening, or perhaps for groups with hypertension who are at especially high risk for cardiovascular events, such as those with nocturnal or early morning hypertension,” observed Dr. Kandzari, director of interventional cardiology and chief scientific officer at the Piedmont Heart Institute in Atlanta.

“This raises the concept of an ‘always on’ effect for renal denervation therapy that may be in distinction to pharmacotherapy and independent of adherence issues,” he added.

Pages

Recommended Reading

Distinguish neurogenic from nonneurogenic orthostatic hypotension
MDedge Internal Medicine
EAGLES: Smoking cessation therapy did not up cardiovascular risk
MDedge Internal Medicine
VIDEO: Triple-antihypertensive pill nails early therapy
MDedge Internal Medicine
MDedge Daily News: Diabetes patients ignore a deadly risk
MDedge Internal Medicine
Consider spironolactone in treatment-resistant hypertension
MDedge Internal Medicine
24-hour ambulatory BP measurements strongly predict mortality
MDedge Internal Medicine
Women’s representation in CV drug trials still lagging
MDedge Internal Medicine
Nebivolol looks like best beta-blocker for hypertension
MDedge Internal Medicine
MDedge Daily News: Is ‘medical aid in dying’ suicide?
MDedge Internal Medicine
New BP guidelines synergize with transformed primary care
MDedge Internal Medicine